ArticleCell cycle (Georgetown, Tex.)2019

MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways.

Cong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.